The optimal first valve choice for patients with aortic stenosis - PCR Tokyo Valves 2024

This session addresses the recent prominence of TAVI as a treatment, particularly in younger patients, prompting discussions on the durability of the device, follow-up procedures and its synergy with surgical alternatives, all aimed at improving patient care through informed decision-making and optimal use of treatment.
Sponsored by Edwards Lifesciences
#tavi
#aorticstenosis
#TAVinTAV
#lifetimemanagement
#durability
More videos on: www.pcronline.com/Cases-resou...

[@clashenriksen961]

Thank you for showing this. Kudos !!!